# Correlation of Serum Level of Perampanel (PER) Level to Cerebrospinal Fluid (CSF) Levels of PER

> **NCT04118829** · PHASE4 · UNKNOWN · sponsor: **Carilion Clinic** · enrollment: 25 (estimated)

## Conditions studied

- Epilepsy
- Seizures

## Interventions

- **DRUG:** Perampanel

## Key facts

- **NCT ID:** NCT04118829
- **Lead sponsor:** Carilion Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-01
- **Primary completion:** 2022-09
- **Final completion:** 2023-03
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2021-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04118829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04118829, "Correlation of Serum Level of Perampanel (PER) Level to Cerebrospinal Fluid (CSF) Levels of PER". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT04118829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*